Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Genetic Research

This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients

CombiGene and the Cell and Gene Therapy Catapult have struck a deal that will move the biotech’s epilepsy therpy towards the clinic.   Swedish biotech CombiGene has combined neuroscience and advances in gene delivery to pioneer and new therapy for epilepsy that has brought down the number of seizures in preclinical studies. The company has joined forces with the UK’s Cell and Gene Therapy (CGT) Catapult to develop the manufacturing processes for CombiGene’s gene therapy, CG01. Once complete, the biotech will be able to move towards clinical trials.

POSSIBLE CAUSE of SUDEP FOUND?

In a recent mouse-model study at The University of Texas MD Anderson Cancer Center researchers found that Mice who have partial deficiency of a certain gene were more likely to develop seizures, and suffer sudden death. — Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.

Lost Password

Register